Genetic Analysis AS (NGM:GEAN)
Sweden
· Delayed Price · Currency is SEK · Price in NOK 0.6700
-0.0250 (-3.60%)
At close: Apr 16, 2025
Genetic Analysis AS Market Cap
Genetic Analysis AS has a market cap or net worth of 30.56 million as of April 17, 2025. Its market cap has increased by 50.80% in one year.
Market Cap
30.56M
Enterprise Value
25.92M
Revenue
20.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.67
Market Cap Chart
Since October 1, 2021, Genetic Analysis AS's market cap has decreased from 235.48M to 30.56M, a decrease of -87.02%. That is a compound annual growth rate of -43.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2025 | 30.56M | 24.95% |
| Dec 30, 2024 | 24.46M | -31.37% |
| Dec 29, 2023 | 35.64M | -34.69% |
| Dec 30, 2022 | 54.57M | -66.71% |
| Dec 30, 2021 | 163.91M | -30.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 90.33B |
| Sectra AB | 52.95B |
| Getinge AB | 52.88B |
| Camurus AB | 33.19B |
| Medicover AB | 32.28B |
| Vitrolife AB | 20.94B |
| Bonesupport Holding AB | 20.38B |
| Vimian Group AB | 19.66B |